SCHEMBL4740218

SCHEMBL4740218

C=C1C=COC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13819397 0.69
SCHEMBL197685 0.69
SCHEMBL369085 0.66
SCHEMBL11230340 0.65
SCHEMBL29603968 0.65
SCHEMBL7263672 0.65
SCHEMBL1666473 0.63
SCHEMBL14751734 0.61
SCHEMBL3473157 0.60
SCHEMBL2359652 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051612-A1 TWO COMPONENT (2K) ACRYLIC COMPOSITION COMPRISING A BIO-RENEWABLE MONOMER HENKEL AG & CO KGAA (DE) 2025-02-13 US disclosed
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
EP-2861555-B1 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING NOVEL RESORCINOL-BASED COMPOUNDS OREAL (FR) 2018-08-29 EP disclosed
EP-2861555-A1 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING NOVEL RESORCINOL-BASED COMPOUNDS L'Oréal (FR) 2015-04-22 EP disclosed
WO-2013189930-A1 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING NOVEL RESORCINOL-BASED COMPOUNDS L'OREAL (FR) 2013-12-27 WO disclosed
WO-2008150335-A1 POLYMERS AND COMPOUNDS PREPARED WITH ALPHA-METHYLENE LACTONES, METHODS THEREFOR, AND COATINGS BASF CORPORATION (US) 2008-12-11 WO disclosed
US-20080293901-A1 POLYMERS AND COMPOUNDS PREPARED WITH ALPHA-METHYLENE LACTONES, METHODS THEREFOR, AND COATINGS BASF CORPORATION 2008-11-27 US disclosed
WO-2008086928-A1 O/W COSMETIC EMULSION COMPRISING A LIPOPHILIC UV SCREENING AGENT, A POLAR OIL AND A POLYSTYRENE-BLOCK-POLY(ACRYLIC ACID-STAT-C1-C4 ALKYL ACRYLATE) DIBLOCK COPOLYMER L'OREAL (FR) 2008-07-24 WO disclosed
US-20080074753-A1 Compound, Polymer and Optical Component MITSUBISHI RAYON CO., LTD. (JP) 2008-03-27 US disclosed
US-7199074-B2 Catalytic composition and its preparation and use for preparing polymers from ethylenically unsaturated monomers ROHM AND HAAS COMPANY (US) 2007-04-03 US disclosed
EP-1073672-B1 ANTIPICORNAVIRAL COMPOUNDS, THEIR PREPARATION AND USE AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6610730-B2 Viricides; protease inbhibitor AGOURON PHARMACEUTICALS, INC. 2003-08-26 US disclosed
EP-1329457-A2 Antipicornaviral compounds, their preparation and use AGOURON PHARMACEUTICALS, INC. (US) 2003-07-23 EP disclosed
US-20030130204-A1 Antipicornaviral compounds and compositons, their pharmaceutical uses, and materials for their synthesis DRAGOVICH PETER SCOTT (US) 2003-07-10 US disclosed
US-6531452-B1 Peptide-like and peptidomimetic compounds that inhibit enzymatic activity of picornaviral 3C proteases and inhibit picornavirus replication AGOURON PHARMACEUTICALS, INC. 2003-03-11 US disclosed
EP-1274682-A2 ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES, AND MATERIALS FOR THEIR SYNTHESIS AGOURON PHARMACEUTICALS, INC. (US) 2003-01-15 EP disclosed
US-20020006943-A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis AGOURON PHARMACEUTICALS, INC. 2002-01-17 US disclosed
WO-2001079167-A2 ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES, AND MATERIALS FOR THEIR SYNTHESIS AGOURON PHARMACEUTICALS, INC. (US) 2001-10-25 WO disclosed
EP-1073672-A1 ANTIPICORNAVIRAL COMPOUNDS, THEIR PREPARATION AND USE AGOURON PHARMACEUTICALS, INC. (US) 2001-02-07 EP disclosed
WO-1999057135-A1 ANTIPICORNAVIRAL COMPOUNDS, THEIR PREPARATION AND USE AGOURON PHARMACEUTICALS, INC. (US) 1999-11-11 WO disclosed